The vaccine named Covifenz was jointly developed by Medicago Inc.
This is the first authorized COVID-19 vaccine developed by a Canadian-based company and uses a plant-based protein technology.
It creates the immunization to combat the virus.
It is developed from a unit of Mitsubishi Chemical Holdings Corp. and Philip Morris International.
The vaccine was found to be 71 per cent effective against symptomatic infection and 100% effective against severe disease caused by COVID-19.